These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 17591595)
1. Determinants of serum adiponectin in persons with and without type 1 diabetes. Maahs DM; Ogden LG; Snell-Bergeon JK; Kinney GL; Wadwa RP; Hokanson JE; Dabelea D; Kretowski A; Eckel RH; Rewers M Am J Epidemiol; 2007 Sep; 166(6):731-40. PubMed ID: 17591595 [TBL] [Abstract][Full Text] [Related]
2. Caribbean female patients with type 2 diabetes mellitus have lower serum levels of adiponectin than nondiabetic subjects. Ezenwaka CE; Kalloo R Neth J Med; 2005 Feb; 63(2):64-9. PubMed ID: 15766010 [TBL] [Abstract][Full Text] [Related]
3. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes. Saraheimo M; Forsblom C; Thorn L; Wadén J; Rosengård-Bärlund M; Heikkilä O; Hietala K; Gordin D; Frystyk J; Flyvbjerg A; Groop PH; Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990 [TBL] [Abstract][Full Text] [Related]
4. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status. Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587 [TBL] [Abstract][Full Text] [Related]
5. Low serum adiponectin is associated with high circulating oxidized low-density lipoprotein in patients with type 2 diabetes mellitus and coronary artery disease. Lautamäki R; Rönnemaa T; Huupponen R; Lehtimäki T; Iozzo P; Airaksinen KE; Knuuti J; Nuutila P Metabolism; 2007 Jul; 56(7):881-6. PubMed ID: 17570246 [TBL] [Abstract][Full Text] [Related]
6. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus. Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467 [TBL] [Abstract][Full Text] [Related]
8. Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes. Wadwa RP; Kinney GL; Ogden L; Snell-Bergeon JK; Maahs DM; Cornell E; Tracy RP; Rewers M Int J Biochem Cell Biol; 2006; 38(5-6):996-1003. PubMed ID: 16271309 [TBL] [Abstract][Full Text] [Related]
9. Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunction. Aso Y; Suganuma R; Wakabayashi S; Hara K; Nakano T; Suetsugu M; Matsumoto S; Nakamachi T; Takebayashi K; Morita K; Inukai T Transl Res; 2009 Oct; 154(4):175-82. PubMed ID: 19766961 [TBL] [Abstract][Full Text] [Related]
10. Serum adiponectin and renal dysfunction in men with type 2 diabetes. Lin J; Hu FB; Curhan G Diabetes Care; 2007 Feb; 30(2):239-44. PubMed ID: 17259488 [TBL] [Abstract][Full Text] [Related]
11. Elevated circulating adiponectin in type 1 diabetes is associated with long diabetes duration. Lindström T; Frystyk J; Hedman CA; Flyvbjerg A; Arnqvist HJ Clin Endocrinol (Oxf); 2006 Dec; 65(6):776-82. PubMed ID: 17121530 [TBL] [Abstract][Full Text] [Related]
12. Association of plasma adiponectin and cardiovascular risk profiles in nondiabetic uremic patients on peritoneal dialysis. Tsao YT; Hsu YJ; Chu NF; Lai CH; Chiu JS; Lin SH J Nephrol; 2008; 21(5):744-52. PubMed ID: 18949730 [TBL] [Abstract][Full Text] [Related]
13. Adiponectin, total antioxidant status, and urine albumin excretion in the low-risk "Golden Years" type 1 diabetes mellitus cohort. Prior SL; Tang TS; Gill GV; Bain SC; Stephens JW Metabolism; 2011 Feb; 60(2):173-9. PubMed ID: 20188385 [TBL] [Abstract][Full Text] [Related]
14. Plasma adiponectin: a predictor of coronary heart disease in hemodialysis patients--a Japanese prospective eight-year study. Takemoto F; Katori H; Sawa N; Hoshino J; Suwabe T; Nakanishi S; Arai S; Fukuda S; Kodaka K; Shimada M; Yamazaki C; Yokoyama K; Nakano Y; Funahashi T; Ubara Y; Yamada A; Takaichi K; Uchida S Nephron Clin Pract; 2009; 111(1):c12-20. PubMed ID: 19052467 [TBL] [Abstract][Full Text] [Related]
16. Serum adiponectin as a useful marker for metabolic syndrome in type 2 diabetic patients. Yun JE; Sull JW; Lee HY; Park E; Kim S; Jo J; Lee SJ; Kim SY; Choi YJ; Jee SH; Huh KB Diabetes Metab Res Rev; 2009 Mar; 25(3):259-65. PubMed ID: 19214966 [TBL] [Abstract][Full Text] [Related]
17. Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy. Kato K; Osawa H; Ochi M; Kusunoki Y; Ebisui O; Ohno K; Ohashi J; Shimizu I; Fujii Y; Tanimoto M; Makino H Clin Endocrinol (Oxf); 2008 Mar; 68(3):442-9. PubMed ID: 17970779 [TBL] [Abstract][Full Text] [Related]
18. Antibodies to periodontal pathogens and coronary artery calcification in type 1 diabetic and nondiabetic subjects. Colhoun HM; Slaney JM; Rubens MB; Fuller JH; Sheiham A; Curtis MA J Periodontal Res; 2008 Feb; 43(1):103-10. PubMed ID: 18230111 [TBL] [Abstract][Full Text] [Related]
19. Influence of diabetes mellitus on long-term survival in systematic off-pump coronary artery bypass surgery. Marcheix B; Vanden Eynden F; Demers P; Bouchard D; Cartier R Ann Thorac Surg; 2008 Oct; 86(4):1181-8. PubMed ID: 18805157 [TBL] [Abstract][Full Text] [Related]
20. High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease. Inoue T; Kotooka N; Morooka T; Komoda H; Uchida T; Aso Y; Inukai T; Okuno T; Node K Am J Cardiol; 2007 Aug; 100(4):569-74. PubMed ID: 17697807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]